Thomas Jefferson University
Supports a portfolio of patient-centered research studies in cancer control and population science, with a focus on improving care delivery and outcomes for patients with cancer and their family caregivers. Works independently while collaborating closely with investigators, clinicians, and research staff to manage the day-to-day operations of clinical research studies in accordance with Good Clinical Practice (GCP). Responsibilities span the full study lifecycle, including startup, recruitment and enrollment, data collection, and closeout. Ensures that all study procedures are conducted in compliance with protocol requirements and applicable regulatory standards. Contributes to the development of operational workflows, training resources, and study documentation to support rigorous and consistent study implementation.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
10001+ employees
Founded
1824
At Thomas Jefferson University in Philadelphia, PA, we are helping you to redefine what’s possible with innovative and tailored education opportunities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Thomas Jefferson University.
38% above the average for this role
Thomas Jefferson University and Sempresto, Inc. Announce Strategic Partnership to Advance Smartphone-Integrated Rescue Medication Platform
Dec 10, 2025
Research Study Coordinator I- Dermatology
Henry Ford Health
Research Study Coordinator III - Cancer Clinical & Translational Research
Henry Ford Health
Research Study Coordinator I- Dermatology
Henry Ford Health
CReST Operations Manager
Cursor
Clinical Research Associate (Part time Contractor)
NAMSA
CReST Operations Manager
Cummins Inc.